Trial Profile
Insulin Detemir Co-Administered With Liraglutide: An Open Label Trial to Assess Insulin Detemir and Liraglutide Pharmacokinetics and Pharmacodynamics Following Liraglutide Therapy in Subjects With Type 2 Diabetes.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 Jan 2017
Price :
$35
*
At a glance
- Drugs Insulin detemir (Primary) ; Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Novo Nordisk
- 19 Sep 2009 Actual patient number (32) added as reported by ClinicalTrials.gov.
- 19 Sep 2009 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
- 19 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.